Company intelligence / Profile preview

Nofil

Cairo, Egypt

Ownership: Private
Development stage: Other

Overview

Nofil Pharma is a pharmaceutical company based in Egypt that focuses on the manufacturing and distribution of generic medications and healthcare products. The company provides a range of therapeutic solutions, including treatments for erectile dysfunction, gastrointestinal issues, and various infectious diseases. Nofil Pharma operates primarily within the Middle East and North Africa (MENA) region, aiming to provide affordable and accessible medicine to the local population. Their portfolio includes well-known regional brands and essential generic formulations.

Therapeutic areas: GastroenterologyMen's HealthInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Nofil.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nofil.

Explore the full profile